Show an ad over header. AMP

I am the FIRST!!!

Here is what we know so far about Trump's coronavirus infection and treatment

It is very difficult to get a comprehensive, trustworthy read on the severity of President Trump's infection.

What they're saying: Sean Conley, Trump's lead doctor, said all weekend that Trump is doing well and experiencing only relatively minor symptoms. And with its many photo ops, the White House is clearly trying to send the same message.


Yes, but: The details we have about Trump's treatment regimen could call that optimism into question.

  • Trump is now taking the steroid dexamethasone, Conley said Sunday. That drug may help save the lives of seriously ill patients, especially those on ventilators. But it's less effective for patients who are only on supplemental oxygen, and has shown no benefit in the mildest cases.
  • Trump is also receiving two other treatments: remdesivir, which has been shown to reduce hospitalization but not to save seriously ill patients' lives, and an experimental antibody treatment from Regeneron Pharmaceuticals.

Between the lines: The fact that Trump's doctors added dexamethasone to his treatment regimen likely means that they were concerned about his condition deteriorating, possibly because of a drop in his oxygen levels, doctors uninvolved in Trump's treatment told Bloomberg.

"It feels like a whole lot of Kremlinology and I'd just be happier if they’d tell us the truth," University of California, San Francisco medical professor Robert Wachter, told STAT.

regular 4 post ff

infinite scroll 4 pff

Substack raising $65 million in venture capital amid newsletter boom

Substack is raising $65 million in new venture capital funding that would value the company at around $650 million, Axios has learned. Existing investor Andreessen Horowitz is leading the round.

Why it matters: Substack, which provides a platform on which writers can publish paid email newsletters and keep most of the revenue, has seen its popularity soar.

Keep reading...Show less

Manchin says he's not willing to abolish filibuster over GOP opposition to Jan. 6 commission

Sen. Joe Manchin (D-W.Va.) said Thursday he is not willing to abolish the legislative filibuster if Republicans block the creation of a bipartisan commission to investigate the deadly Jan. 6 Capitol riot, which they are set to do within hours.

Why it matters: Manchin — a crucial moderate swing vote — has blasted GOP leadership over the Jan. 6 commission and said "there is no excuse for any Republican to vote against" the bill. But his view has still not changed on eliminating or altering the filibuster, even if it prevents his party from passing key legislation.

Keep reading...Show less

Private colleges across America can't pay their bills

Behind the scenes in colleges across the U.S.,institutions are having trouble paying their bills.

Why it matters: There’s a reckoning coming in higher education — especially for smaller, private liberal arts schools — that’s been years in the making. In obvious ways, COVID accelerated some of the trends, but college finances have been hurting for a while.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;